Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia

Journal of Clinical Epidemiology

Volumn 65, Issue 6, 2012, Pages 627-634

  Sung, Lillian ^a   Alibhai, Shabbir M ^b   Ethier, Marie Chantal ^a   Teuffel, Oliver ^a   Cheng, Sylvia ^a   Fisman, David ^c   Regier, Dean A ^d,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adult; Children; Conjoint analysis; Discrete choice experiment; Febrile neutropenia; Outpatient management

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER PATIENT; CHILD; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ALGORITHMS; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHILD; CHOICE BEHAVIOR; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, PARENTERAL; INPATIENTS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; ONTARIO; PARENTS; PATIENT PREFERENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84860254785     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.11.008     Document Type: Article

References (26)

1. W.T. Hughes, D. Armstrong, G.P. Bodey, E.J. Bow, A.E. Brown, and T. Calandra 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 2002 730 751
2. G.P. Bodey, M. Buckley, Y.S. Sathe, and E.J. Freireich Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 1966 328 340
3. W.T. Hughes, D. Armstrong, G.P. Bodey, A.E. Brown, J.E. Edwards, and R. Feld 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America Clin Infect Dis 25 1997 551 573
4. W.T. Hughes, D. Armstrong, G.P. Bodey, R. Feld, G.L. Mandell, and J.D. Meyers From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever J Infect Dis 161 1990 381 396
5. A. Freifeld, D. Marchigiani, T. Walsh, S. Chanock, L. Lewis, and J. Hiemenz A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy N Engl J Med 341 5 1999 305 311
6. W.V. Kern, A. Cometta, R. De Bock, J. Langenaeken, M. Paesmans, and H. Gaya Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer N Engl J Med 341 5 1999 312 318
7. L. Sung, B.M. Feldman, G. Schwamborn, D. Paczesny, A. Cochrane, and M.L. Greenberg Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences J Clin Oncol 22 2004 3922 3929
8. M. Ryan, and S. Farrar Using conjoint analysis to elicit preferences for health care Br Med J 320 7248 2000 1530 1533
9. K. Lancaster A new approach to consumer theory J Polit Econ 74 1966 132 157
10. E.W. de Bekker-Grob, M. Ryan, and K. Gerard Discrete choice experiments in health economics: a review of the literature Health Econ 2010 Epub 2010/12/21
11. I. Krinsky, and A.L. Robb On approximating the statistical properties of elasticities Rev Econ Stat 68 1990 715 719
12. I. Krinsky, and A.L. Robb On approximating the statistical properties of elasticities: a correction Rev Econ Stat 72 1990 189 190
13. J. Hall, P. Kenny, M. King, J. Louviere, R. Viney, and A. Yeoh Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination Health Econ 11 5 2002 457 465
14. O. Teuffel, E. Amir, S.M. Alibhai, J. Beyene, and L. Sung Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer Pediatrics 127 2011 e279 e286
15. M. Ryan, and K. Gerard Using discrete choice experiments to value health care programmes: current practice and future research reflections Appl Health Econ Health Policy 2 1 2003 55 64
16. H.E. Innes, D.B. Smith, S.M. O'Reilly, P.I. Clark, V. Kelly, and E. Marshall Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study Br J Cancer 89 1 2003 43 49
17. C.A. Mullen, and G.R. Buchanan Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient J Clin Oncol 8 1990 1998 2004
18. E. Orudjev, and B.J. Lange Evolving concepts of management of febrile neutropenia in children with cancer Med Pediatr Oncol 39 2 2002 77 85
19. C.A. Mullen, D. Petropoulos, W.M. Roberts, M. Rytting, T. Zipf, and K.W. Chan Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients Cancer 86 1999 126 134
20. A.S. Petrilli, L.S. Dantas, M.C. Campos, C. Tanaka, V.C. Ginani, and A. Seber Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial Med Pediatr Oncol 34 2 2000 87 91
21. E.P. Baorto, V.M. Aquino, C.A. Mullen, G.R. Buchanan, and M.R. DeBaun Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia Cancer 92 2001 909 913
22. L. Vidal, M. Paul, I. Ben-Dor, E. Pokroy, K. Soares-Weiser, and L. Leibovici Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients Cochrane Database Syst Rev 4 2004 CD003992
23. E. Castagnola, D. Paola, R. Giacchino, and C. Viscoli Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review J Hematother Stem Cell Res 9 2000 645 649
24. H. Paganini, S. Gomez, S. Ruvinsky, P. Zubizarreta, A. Latella, and L. Fraquelli Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina Cancer 97 2003 1775 1780
25. E.B. Rubenstein, K. Rolston, R.S. Benjamin, J. Loewy, C. Escalante, and E. Manzullo Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer Cancer 71 1993 3640 3646
26. V.M. Aquino, L. Herrera, E.S. Sandler, and G.R. Buchanan Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer Cancer 88 2000 1710 1714